CN102389494A - Chinese medicine for treating diabetic heart diseases - Google Patents

Chinese medicine for treating diabetic heart diseases Download PDF

Info

Publication number
CN102389494A
CN102389494A CN201110258504XA CN201110258504A CN102389494A CN 102389494 A CN102389494 A CN 102389494A CN 201110258504X A CN201110258504X A CN 201110258504XA CN 201110258504 A CN201110258504 A CN 201110258504A CN 102389494 A CN102389494 A CN 102389494A
Authority
CN
China
Prior art keywords
chinese medicine
parts
blood
radix
fine powder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201110258504XA
Other languages
Chinese (zh)
Inventor
刘新壮
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lvyuan Qiuzheng Technology Development Co Ltd
Original Assignee
Lvyuan Qiuzheng Technology Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lvyuan Qiuzheng Technology Development Co Ltd filed Critical Lvyuan Qiuzheng Technology Development Co Ltd
Priority to CN201110258504XA priority Critical patent/CN102389494A/en
Publication of CN102389494A publication Critical patent/CN102389494A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a Chinese medicine for treating diabetic heart diseases and belongs to the field of Chinese medicines for treating diabetics. The Chinese medicine aims to have a good effect and quick response, and is prepared from figwort root, medlar, rosewood heart wood, notoginseng root, angelica sinensis, lucid ganoderma and the like. The Chinese medicine has the effects of strengthening body resistance and archaeus, invigorating qi and nourishing blood, promoting blood circulation and removing blood stasis, and promoting coronary circulation and relieving pain; and has the advantages of accurate medicinal effect and quick response.

Description

A kind of Chinese medicine of treating diabetic cardiopathy
Technical field
The invention belongs to the field of Chinese medicines of treatment diabetes.
Background technology
Diabetic cardiopathy (being called for short sugared cardiopathia) is meant the heart disease that diabetics is concurrent, is due to cardiovascular injuries pathological changes, microangiopathies and the autonomic neuropathy that on the disorderly basis of metabolism such as sugar, fat, is taken place.Being the diabetes most common complication, also is the main cause of death of diabetics.According to statistics, diabetics 70% is died from diabetic cardiopathy.The present Chinese medicine aspect that is intended to treat diabetic cardiopathy, the deficiency of two aspects of existence: the one, effect is obvious inadequately, and the 2nd, it is slower to take effect.So that many diabetic cardiopathy patients stand the torment of tachycardia, position hypotension, feeling of oppression and pain in the chest for a long time owing to can not get the treatment of active drug, face the danger of heart failure, myocardial infarction, patient and family members thereof are dissatisfied to this.
To problem set forth above, the present invention provides a kind of Chinese medicine of treating diabetic cardiopathy, and it can solve, and this type of Chinese medicine effect was obvious inadequately in the past, the slower problem that takes effect, and effective, instant effect, it is definite to have drug effect, the advantage of quick result.
Summary of the invention
The present invention realizes through following technical scheme:
1, a kind of Chinese medicine of treating diabetic cardiopathy adopts the raw material of Chinese medicine preparation, and the weight proportion of raw material of Chinese medicine is:
Radix Scrophulariae 4---6 parts of 12 parts of Fructus Lycii 6---18 parts of Lignum Dalbergiae Odoriferaes 2---
Radix Notoginseng 1---18 parts of 3 parts of Radix Salviae Miltiorrhizaes 6---18 portions of Ganodermas 6---
The Chinese medicine of this treatment diabetic cardiopathy is processed by following method:
(1) by above-mentioned weight ratio, Radix Scrophulariae, Fructus Lycii, Lignum Dalbergiae Odoriferae, Radix Salviae Miltiorrhizae, Ganoderma are extracted through conventional water extraction process, process extractum, oven dry is pulverized, and gets the extract fine powder;
(2) by above-mentioned weight ratio, Radix Notoginseng is ground into fine powder, mixes, stir, process Chinese medicine granules, capsule, tablet with above-mentioned (1) extract fine powder.
The present invention is according to the folk tradition prescription, and the theory according to traditional Chinese medical science the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling develops meticulously.We think in research, the general hypoimmunity of diabetics, and this disease is many by diabetes with the passing of time, scorching yin-damaging and Qi consuming, deficiency of both QI and YIN is due to the heart arteries and veins stasis of blood hinders.In morbific many factors, hypoimmunity is the very corn of a subject and key.So the present invention attaches most importance to enhancing immunity, benefiting QI and nourishing blood, blood circulation promoting and blood stasis dispelling is obtained good efficacy.At present; Western medicine and Chinese medicine that multiple treatment heart disease, coronary heart disease are arranged on the China market; Wherein transcendent, by the patient extensively cognitive have four kinds: the advantage of nitroglycerin, SUXIAO JIUXIN WAN is to help meet an urgent need when the chest pain unexpected generation uncomfortable in chest, lets the patient avoid myocardial infarction; The advantage of Isosorbide fat sheet, Radix Salviae Miltiorrhizae drop pill is in 8 ~ 12 hours time, control chest pain slight generation uncomfortable in chest or not generation.And the advantage of Chinese medicine of the present invention is fundamentally to improve blood supply of cardiac muscle, let chest pain uncomfortable in chest be not within 12 hours but in the long time, gradually reduce, alleviate, until not taking place.We can say that the present invention compares with above-mentioned four kinds of above the ordinary Chinese medicine and western medicine, the former stresses to control " mark ", and this medicine stresses to control " basis ", is each have their own advantage, each have their own purposes.In addition, also have an important difference, medicine of the present invention is the treatment diabetic cardiopathy, but not general heart disease has general character between them, individual character is also arranged.Chinese medicine of the present invention has the obvious treatment effect to symptoms such as the distinctive tranquillization tachycardia of diabetic cardiopathy patient, position hypotension.Thus, this patient is many a kind of better optimize therapeutic scheme---" 1+1+1 ", promptly uses nitroglycerin (SUXIAO JIUXIN WAN) " emergency "; Do not show effect in 12 hours with Isosorbide fat sheet (Radix Salviae Miltiorrhizae drop pill) control; Alleviate macroangiopathy, microangiopathies and the autonomic neuropathy of sugared cardiopathia with Chinese medicine of the present invention, thereby reduce chest pain generation uncomfortable in chest.Value of the present invention that Here it is.Ganoderma, Fructus Lycii the body resistance strengthening and constitution consolidating among the we, benefiting QI and nourishing blood, tranquilizing by nourishing the heart, enhancing human body immunity power, " removing " effect of immunity makes blood clean, and is no longer sticky, and rich mobile, this is the basis of improving blood supply of cardiac muscle; Minister is with Radix Salviae Miltiorrhizae, Radix Notoginseng nourshing blood and promoting blood circulation, blood-activating analgetic, with regard to the effect of Radix Salviae Miltiorrhizae, Radix Salviae Miltiorrhizae is gone into conscience two through blood system, bitter can using pungent drugs for dispersion and bitter drugs for purgation so that the merit of blood circulation promoting and blood stasis dispelling to be arranged, wins heat owing to it is cold in nature, thus can control scorching impairment of YIN, the heat in blood stasis of blood stagnate due at demonstrate,proving; Ganoderma, Fructus Lycii and Radix Salviae Miltiorrhizae, Radix Notoginseng are share, the prosperous hemapodium of gas, and tissue regeneration promoting blood and blood stasis removing blood, " reparation " effect of immunity, softening arteria coronaria blood vessel and myocardium blood capillary reduce the resistance of the blood vessel stasis of blood, make blood supply of cardiac muscle full; Assistant is with the YIN nourishing of Radix Scrophulariae clearing away heat and cooling blood; The hemostasis of Lignum Dalbergiae Odoriferae clots absorbing, the analgesia of regulating the flow of vital energy is to alleviate the thoracic obstruction costalgia that heart ischemia produces.All medicine compatibilities bring out the best in each other, and play the body resistance strengthening and constitution consolidating altogether, benefiting QI and nourishing blood, replenishing YIN and removing heat, blood circulation promoting and blood stasis dispelling, the merit of coronary circulation-promoting pain-relieving.Make a general survey of full side, the merit of existing element culturing fixed folder does not have the numbness that consumes impairment of QI the moon again, and residence is mended in logical, the good recipe that nourishes heart really and promote blood circulation.Effective, instant effect, it is definite to have drug effect, the advantage of quick result.
The specific embodiment
Through following embodiment the present invention is done and to specify:
1, get following prescription (weight is unit by gram):
Radix Scrophulariae 400 gram Fructus Lycii 600 gram Lignum Dalbergiae Odoriferaes 200 grams
Radix Notoginseng 100 gram Radix Salviae Miltiorrhizaes 600 kairine sesames 600 grams
Press predetermined weight, Radix Scrophulariae, Fructus Lycii, Lignum Dalbergiae Odoriferae, Radix Salviae Miltiorrhizae, Ganoderma are extracted, get extract fine powder 240 grams with conventional water extraction process; Radix Notoginseng is ground into fine powder, mixes, stir with said extracted thing fine powder; Process fine particle; The capsule of packing into No. 0 is processed 1133 of Chinese medicinal capsules, and every capsules includes Chinese medicine fine powder and extract 0.3 gram.
2, get following prescription (weight is unit by gram):
Radix Scrophulariae 800 gram Fructus Lycii 1200 gram Lignum Dalbergiae Odoriferaes 400 grams
Radix Notoginseng 180 gram Radix Salviae Miltiorrhizaes 1200 kairine sesames 1200 grams
By above-mentioned same method, process 2200 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.3 gram.
3, get following prescription (weight is unit by gram):
Radix Scrophulariae 1200 gram Fructus Lycii 1800 gram Lignum Dalbergiae Odoriferaes 600 grams
Radix Notoginseng 260 gram Radix Salviae Miltiorrhizaes 1800 kairine sesames 1800 grams
By above-mentioned same method, process 3266 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.3 gram.
4, get following prescription (by weight):
2 parts of 9 parts of Lignum Dalbergiae Odoriferaes of 5 parts of Fructus Lycii of Radix Scrophulariae
9 parts of 9 portions of Ganodermas of 1 part of Radix Salviae Miltiorrhizae of Radix Notoginseng
By above-mentioned same method, process Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.3 gram.
5, get following prescription (by weight):
4 parts of 15 parts of Lignum Dalbergiae Odoriferaes of 10 parts of Fructus Lycii of Radix Scrophulariae
15 parts of 15 portions of Ganodermas of 2 parts of Radix Salviae Miltiorrhizaes of Radix Notoginseng
By above-mentioned same method, process Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.3 gram.
Clinical data:
The present invention is an example with traditional Chinese medical science diabetic cardiopathy, through 32 routine clinical observations.Selecting the tcm diagnosis diabetic cardiopathy is standard: the diabetics tachycardia, and heart rate is greater than 90 times/minute; The position hypotension is arranged, blood pressure drops 20 ~ 30 millimetress of mercury when clinostatism changes upright; Chest pain is uncomfortable in chest, and limbs are weak; Cardiopalmus hyperhidrosis, often insomnia; Diabetics is not when having coronary heart disease, and electrocardiogram has the ST section to change, and ultrasoundcardiogram shows myocardial hypertrophy.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, male's 17 examples, women's 15 examples do not have other serious disease, and the age is 52 years old-81 years old, 64.3 years old mean age.
Efficacy determination:
1, produce effects: tachycardia disappears, and heart rate is less than 90 times/minute; The position hypotension is significantly alleviated, and systolic pressure descended less than 15 millimetress of mercury when clinostatism changed upright, and diastolic pressure descends less than 10 millimetress of mercury; Chest pain obvious alleviation uncomfortable in chest, weak disappearance, on one's body energetically; Insomnia, hyperhidrosis are obviously alleviated; ECG ST section changes obviously and improves, and ultrasoundcardiogram shows the myocardial hypertrophy alleviation.
2, effective: tachycardia, position hypotension are alleviated, and uncomfortable in chest, weak, hyperhidrosis, insomnia make moderate progress;
3, invalid: the disease no change.
During clinical experiment, withdraw other medicines and health nutrient.Taking the Chinese medicinal capsule that the specific embodiment of the invention 2 is made, observed 6 months, is a course of treatment.Instructions of taking: every day 2 times, each 4 capsules, every capsules include Chinese medicine fine powder and extract 0.3 gram, warm water delivery service after meal, symptom promptly has alleviation after 1 month, take 6 months after, symptom is obviously improved.32 philtrums of clinical experiment, produce effects 15 people, effective 14 people, invalid 3 people, total effective rate 90.6%.

Claims (1)

1. a Chinese medicine of treating diabetic cardiopathy is characterized in that, said Chinese medicine is to adopt the raw material of Chinese medicine preparation, and the weight proportion of raw material of Chinese medicine is:
Radix Scrophulariae 4---6 parts of 12 parts of Fructus Lycii 6---18 parts of Lignum Dalbergiae Odoriferaes 2---
Radix Notoginseng 1---18 parts of 3 parts of Radix Salviae Miltiorrhizaes 6---18 portions of Ganodermas 6---
The Chinese medicine of this treatment diabetic cardiopathy is processed by following method:
(1) by above-mentioned weight ratio, Radix Scrophulariae, Fructus Lycii, Lignum Dalbergiae Odoriferae, Radix Salviae Miltiorrhizae, Ganoderma are extracted through conventional water extraction process, process extractum, oven dry is pulverized, and gets the extract fine powder;
(2) by above-mentioned weight ratio, Radix Notoginseng is ground into fine powder, mixes, stir, process Chinese medicine granules, capsule, tablet with above-mentioned (1) extract fine powder.
CN201110258504XA 2011-09-03 2011-09-03 Chinese medicine for treating diabetic heart diseases Pending CN102389494A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201110258504XA CN102389494A (en) 2011-09-03 2011-09-03 Chinese medicine for treating diabetic heart diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201110258504XA CN102389494A (en) 2011-09-03 2011-09-03 Chinese medicine for treating diabetic heart diseases

Publications (1)

Publication Number Publication Date
CN102389494A true CN102389494A (en) 2012-03-28

Family

ID=45856959

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201110258504XA Pending CN102389494A (en) 2011-09-03 2011-09-03 Chinese medicine for treating diabetic heart diseases

Country Status (1)

Country Link
CN (1) CN102389494A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102973787A (en) * 2012-11-07 2013-03-20 溧阳市天目湖保健品有限公司 Traditional Chinese medicine used for treating diabetic cardiac autonomic neuropathy
CN102973785A (en) * 2012-11-07 2013-03-20 溧阳市天目湖保健品有限公司 Traditional Chinese medicine for treatment of diabetic cardiomyopathy

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101843661A (en) * 2009-09-25 2010-09-29 北京绿源求证科技发展有限责任公司 Chinese medicament for treating angina

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101843661A (en) * 2009-09-25 2010-09-29 北京绿源求证科技发展有限责任公司 Chinese medicament for treating angina

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
李静等,1: "糖尿病心脏病中医药治疗现状", 《中国中医急症》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102973787A (en) * 2012-11-07 2013-03-20 溧阳市天目湖保健品有限公司 Traditional Chinese medicine used for treating diabetic cardiac autonomic neuropathy
CN102973785A (en) * 2012-11-07 2013-03-20 溧阳市天目湖保健品有限公司 Traditional Chinese medicine for treatment of diabetic cardiomyopathy

Similar Documents

Publication Publication Date Title
CN102380032A (en) Traditional Chinese medicine for treating diabetic heart disease
CN102389493A (en) Traditional Chinese medicine for treating diabetic heart disease
CN102389494A (en) Chinese medicine for treating diabetic heart diseases
CN102172378A (en) Traditional Chinese medicine for treating diabetic coronary heart disease
CN101843755A (en) Chinese medicament for treating diabetic cardiopathy
CN101843878B (en) Chinese medicament for treating diabetic cardiopathy
CN101843753B (en) Chinese medicament for treating angina
CN102327387A (en) Chinese medicine for treating diabetic heart disease
CN102379981A (en) Chinese medicament for treating diabetic heart disease
CN102670848A (en) Chinese medicine for treating diabetic heart disease
CN102379980A (en) Traditional Chinese medicine for treating diabetic heart diseases
CN101843807A (en) Chinese medicament for treating diabetic cardiopathy
CN101991648A (en) Traditional Chinese medicine for treating diabetic coronary heart disease
CN102670843A (en) Chinese medicine for treating diabetic heart disease
CN102631529A (en) Traditional Chinese medicine for treating diabetic heart disease
CN102631468A (en) Traditional Chinese medicine (TCM) for treating diabetic heart disease
CN101991743A (en) Traditional Chinese medicine for treating diabetic heart disease
CN102091229A (en) Traditional Chinese medicine for treating diabetic coronary heart disease
CN101991647A (en) Traditional Chinese medicine for treating diabetic coronary heart diseases
CN102379976A (en) Traditional Chinese medicine for treating diabetic heart disease
CN102614314A (en) Traditional Chinese medicine for treating diabetic heart disease
CN101972327A (en) Traditional Chinese medicine for treating diabetic heart disease
CN101983640A (en) Traditional Chinese medicine for treating diabetic heart disease
CN101850054B (en) Chinese medicament for treating diabetic heart diseases
CN101843832B (en) Chinese medicament for treating coronary disease

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20120328